[Modern therapy and after-care in urogenital tuberculosis].
The present therapy of the urogenital tuberculosis is based on the effective medicaments (rifampizin, isonicotinic acid hydrazid, streptomycin, and ethambutol). It rests on an optimum dosage in connection with a best suited combination, taking into consideration the relations of sensitiveness and side effects as well as consequent long-term treatment. It is referred to the possibility of additional administrations of corticosteroid preparations and it is taken notice to the necessity also to treat unspecific mixed infections. Under the modern chemotherapy with bactericidal effect a stable negativation practically always develops within 3 months. Actual recidivations were not seen during the last 12 years. Apart from a compilation of the indications to nephrectomy references to possibilities of plastic surgical corrections of the urinary system are given. Two tables give information about the patients who were operatively treated during the last 15 years. A close collaboration of the various therapeutic institutions with a consulting urologist -- particularly in problematic and advanced cases of the disease -- nearly always saves the patient with urogenital tuberculosis from invalidism.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D005837:Genitalia, Male / Q000601:surgery; D006760:Hospitalization; D006801:Humans; D007539:Isonicotinic Acids / Q000627:therapeutic use; D008297:Male; D009392:Nephrectomy; D012293:Rifampin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D014401:Tuberculosis, Urogenital / Q000188:drug therapy*; D014566:Urogenital System / Q000601:surgery
D000305:Adrenal Cortex Hormones; D007539:Isonicotinic Acids; D004977:Ethambutol; D012293:Rifampin; D013307:Streptomycin
Moderne Therapie und Nachsorge bei urogenitaltuberkulose.